A new modified virus designed to treat an aggressive form of brain tumor has been found to extend the survival of patients for years. The clinical trial has finished its phase 1 and will move on to the next phase.
A new modified virus designed to treat an aggressive form of brain tumor has been found to extend the survival of patients for years. The clinical trial has finished its phase 1 and will move on to the next phase.
Share this Article
Recommended